A quick question about the R&D expense.
I am working at an early-stage BioTech company that has not yet generated any revenue. Right now we are trying to find investors of our series A.
When conducting the valuation, how to treat the R&D expense? Can we capitalize them as assets instead of expenses, then boost the EBITDA? Or it is not allowed to do so under regulation.
Thanks for any advise in advance!!
R&D - Asset or Expense?
More on Searchfunder
We maintain partnerships with database providers that make searching more effective, efficient and affordable along with features that help searchers find deals and investors and vice versa.